
zzso is often used to manage zzso pain in patients with zzso However, it occasionally causes zzso effects such as vivid dreams, zzso zzso hallucinations, and altered body zzso 

To examine whether gradual dose zzso of zzso for management of zzso pain prevents zzso effects in patients with advanced zzso 

This was a retrospective chart zzso We administered zzso when zzso pain in patients with advanced cancer became zzso to zzso and oral zzso zzso The starting dose of zzso was 10 zzso by continuous intravenous zzso The dose was gradually increased by 10 zzso every 4 to 6 hours to 50 zzso or until the pain was zzso It was subsequently increased by 25 zzso every 12 to 24 hours until the pain was zzso 

For this study, we enrolled 46 patients with advanced zzso The mean age was zzso zzso zzso zzso The mean dose at onset of action and maximum dose of zzso were 56 zzso 58 and 272 zzso 214 zzso zzso The mean pain intensity zzso rating zzso decreased significantly from zzso zzso zzso to zzso zzso zzso after the administration of zzso zzso zzso zzso The effectiveness was zzso No zzso effect of less than 300 zzso was observed during the introduction phase even though zzso drugs were not zzso zzso sedation was observed in 3 patients zzso as the only adverse effect during the introduction zzso 

zzso dose zzso of zzso for management of zzso pain can prevent zzso effects in patients with advanced zzso 

